- Home
- IRT vs PTGX Comparison
IRT vs PTGX Comparison
Compare IRT & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRT
- PTGX
- Stock Information
- Founded
- IRT 2009
- PTGX 2006
- Country
- IRT United States
- PTGX United States
- Employees
- IRT N/A
- PTGX N/A
- Industry
- IRT Real Estate Investment Trusts
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- IRT Real Estate
- PTGX Health Care
- Exchange
- IRT Nasdaq
- PTGX Nasdaq
- Market Cap
- IRT 3.8B
- PTGX 4.0B
- IPO Year
- IRT 2013
- PTGX 2016
- Fundamental
- Price
- IRT $15.12
- PTGX $76.69
- Analyst Decision
- IRT Buy
- PTGX Strong Buy
- Analyst Count
- IRT 7
- PTGX 9
- Target Price
- IRT $22.14
- PTGX $78.11
- AVG Volume (30 Days)
- IRT 2.9M
- PTGX 1.5M
- Earning Date
- IRT 10-29-2025
- PTGX 10-31-2025
- Dividend Yield
- IRT 4.50%
- PTGX N/A
- EPS Growth
- IRT N/A
- PTGX N/A
- EPS
- IRT 0.12
- PTGX 0.80
- Revenue
- IRT $645,404,000.00
- PTGX $209,180,000.00
- Revenue This Year
- IRT $4.55
- PTGX N/A
- Revenue Next Year
- IRT $4.92
- PTGX $142.86
- P/E Ratio
- IRT $125.61
- PTGX $95.33
- Revenue Growth
- IRT N/A
- PTGX N/A
- 52 Week Low
- IRT $15.07
- PTGX $33.31
- 52 Week High
- IRT $22.26
- PTGX $93.25
- Technical
- Relative Strength Index (RSI)
- IRT 23.75
- PTGX 59.10
- Support Level
- IRT $16.08
- PTGX $73.08
- Resistance Level
- IRT $16.47
- PTGX $77.66
- Average True Range (ATR)
- IRT 0.32
- PTGX 4.86
- MACD
- IRT -0.04
- PTGX -0.33
- Stochastic Oscillator
- IRT 3.91
- PTGX 39.74
About IRT Independence Realty Trust Inc.
Independence Realty Trust Inc is a real estate investment trust (REIT) that acquires, owns, operates, improves and manages multifamily apartment communities across non-gateway U.S. markets. It owns and operates multifamily apartment properties, across non-gateway U.S markets, including Louisville, Memphis, Atlanta, and Raleigh. The company is focused on gaining scale within key amenity-rich submarkets that offer school districts, retail, and various employment centers.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.